Demographic data of premature neonates enrolled in the study
| Non-Exposed (N=9) | Opioid-Exposed (N=8) | P value | |
|---|---|---|---|
| Gestational Age (wks) | 35.4 (35.1, 36.6) | 35.4 (35.0, 36.1) | 0.74 |
| Female | 5 (55.6%) | 4 (50.0%) | 0.82 |
| C Section | 4 (44.4%) | 5 (62.5%) | 0.46 |
| Birth Weight (g) | 2574.44 ± 382.89 | 2405.88 ± 642.49 | 0.52 |
| Birth Weight Percentile | 48.89 ± 28.25 | 34.88 ± 39.26 | 0.41 |
| Head Circumference (cm) | 32.41 ± 0.67 | 31.44 ± 2.29 | 0.24 |
| Head Circumference Percentile | 56.22 ± 14.05 | 42.38 ± 39.59 | 0.34 |
| Length (cm) | 48.08 ± 1.73 | 44.29 ± 3.38 | 0.01 |
| Length Percentile | 64.78 ± 17.96 | 40.98 ± 34.10 | 0.09 |
| Apgar 1 minutes | 8.0 (8.0, 9.0) | 8.5 (6.0, 9.0) | 0.79 |
| Apgar 5 minutes | 9.0 (8.0, 9.00) | 9.0 (8.8, 9.0) | 0.92 |
| Needing pharmacotherapy | NA | 2 (25%) | NA |
| Maternal Opioids Buprenorphine Methadone | NA | 8 4 (50.0%) 4 (50.0%) | NA |
wks=weeks, g=grams, cm=centimeters, NA=not applicable. Data are presented as mean ± standard deviation, median (interquartile range) for continuous measures, and N (%) for categorical measures.